Submucosal tunneling endoscopic resection for large symptomatic submucosal tumors of the esophagus: A clinical analysis of 24 cases
Studies evaluating submucosal tunneling endoscopic resection (STER) for the treatment of upper gastrointestinal submucosal tumors (SMTs) have recently increased. However, the efficacy and safety of STER for the treatment of large symptomatic SMTs in the esophagus have not been well investigated. The...
Gespeichert in:
| Veröffentlicht in: | The Turkish journal of gastroenterology 2020-01, Vol.31 (1), p.42-48 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 48 |
|---|---|
| container_issue | 1 |
| container_start_page | 42 |
| container_title | The Turkish journal of gastroenterology |
| container_volume | 31 |
| creator | Wang, Guo-Xiang Yu, Guang Xiang, Yan-Li Miu, Yang-De Wang, Hong-Gang Xu, Mei-Dong |
| description | Studies evaluating submucosal tunneling endoscopic resection (STER) for the treatment of upper gastrointestinal submucosal tumors (SMTs) have recently increased. However, the efficacy and safety of STER for the treatment of large symptomatic SMTs in the esophagus have not been well investigated. The aim of the present study was to evaluate the efficacy and safety of STER for the treatment of large symptomatic SMTs in the esophagus.
A total of 24 patients with large symptomatic SMTs in the esophagus who underwent STER in our hospitals between January 2015 and May 2018 were included in the study. The tumors were confirmed to be of muscularis propria layer origin. Treatment outcomes, complications, and follow-up results were retrospectively analyzed.
All 24 lesions were resected en bloc with STER. The mean maximum transverse diameter of the lesions was 4.7 (3.5-6.5) cm. The mean maximum longitudinal diameter of the lesions was 2.1 (1.5-3.0) cm. The mean duration from mucosal incision to complete mucosal closure was 65 (50-115) min. Postoperative pathological diagnosis confirmed 18 cases with leiomyomas, 4 cases with stromal tumors, and 2 cases with schwannomas. There were no major complications. There were no residual lesions or disease recurrence during follow-up.
STER is safe and effective for the treatment of large symptomatic SMTs of muscularis propria layer origin in the esophagus. |
| doi_str_mv | 10.5152/tjg.2020.19062 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7075684</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A623177926</galeid><sourcerecordid>A623177926</sourcerecordid><originalsourceid>FETCH-LOGICAL-c524t-90f1f340f1d01027b6ff7edac2a0551e93a384dc3cabff5d284e9a6909e0ddfe3</originalsourceid><addsrcrecordid>eNqdks2LFDEQxYMo7rh69SgBL156rCTdSbcHYVj8ggUP6jlk0pWeLN1Jm3QLc_YfN7O7rit4koIUpH7vUQmPkOcMtg1r-Ovlathy4LBlHUj-gGw4q9uqkaAekg0TAFXd1e0ZeZLzFYBomeSPyZngAJ1kYkN-fln302pjNiNd1hBw9GGgGPqYbZy9pQkz2sXHQF1MdDRpQJqP07zEySxlnu_rp5gyjY4uB6SY43www5rf0B21xdbbwphgxmP21xSvqTUZ81PyyJkx47Pbfk6-vX_39eJjdfn5w6eL3WVlG14vVQeOOVGXswcGXO2lcwp7Y7mBpmHYCSPaurfCmr1zTc_bGjsjO-gQ-t6hOCdvb3znsjP2FsOSzKjn5CeTjjoar_-eBH_QQ_yhFahGtnUxeHVrkOL3FfOiJ58tjqMJGNesuWhANIIpVtCXN-hgRtQ-uFgc7QnXO8kLojouC7X9B1Wqx8nbGND5cv8_Ag6yU0r9EdgUc07o7p7LQJ8SpEuC9ClB-jpBRfDi_ifd4b8jI34B0u_EWA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2350353171</pqid></control><display><type>article</type><title>Submucosal tunneling endoscopic resection for large symptomatic submucosal tumors of the esophagus: A clinical analysis of 24 cases</title><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Wang, Guo-Xiang ; Yu, Guang ; Xiang, Yan-Li ; Miu, Yang-De ; Wang, Hong-Gang ; Xu, Mei-Dong</creator><creatorcontrib>Wang, Guo-Xiang ; Yu, Guang ; Xiang, Yan-Li ; Miu, Yang-De ; Wang, Hong-Gang ; Xu, Mei-Dong ; Endoscopy Center, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China ; Department of Gastroenterology, Taizhou Municipal Hospital, Taizhou, Zhejiang, China</creatorcontrib><description>Studies evaluating submucosal tunneling endoscopic resection (STER) for the treatment of upper gastrointestinal submucosal tumors (SMTs) have recently increased. However, the efficacy and safety of STER for the treatment of large symptomatic SMTs in the esophagus have not been well investigated. The aim of the present study was to evaluate the efficacy and safety of STER for the treatment of large symptomatic SMTs in the esophagus.
A total of 24 patients with large symptomatic SMTs in the esophagus who underwent STER in our hospitals between January 2015 and May 2018 were included in the study. The tumors were confirmed to be of muscularis propria layer origin. Treatment outcomes, complications, and follow-up results were retrospectively analyzed.
All 24 lesions were resected en bloc with STER. The mean maximum transverse diameter of the lesions was 4.7 (3.5-6.5) cm. The mean maximum longitudinal diameter of the lesions was 2.1 (1.5-3.0) cm. The mean duration from mucosal incision to complete mucosal closure was 65 (50-115) min. Postoperative pathological diagnosis confirmed 18 cases with leiomyomas, 4 cases with stromal tumors, and 2 cases with schwannomas. There were no major complications. There were no residual lesions or disease recurrence during follow-up.
STER is safe and effective for the treatment of large symptomatic SMTs of muscularis propria layer origin in the esophagus.</description><identifier>ISSN: 1300-4948</identifier><identifier>EISSN: 2148-5607</identifier><identifier>DOI: 10.5152/tjg.2020.19062</identifier><identifier>PMID: 32009613</identifier><language>eng</language><publisher>Turkey: AVES</publisher><subject>Care and treatment ; Diseases ; Endoscopy ; Esophageal cancer ; Hospitals ; Original ; Photographic industry ; Recurrence (Disease) ; Relapse ; Surgery ; Tumors</subject><ispartof>The Turkish journal of gastroenterology, 2020-01, Vol.31 (1), p.42-48</ispartof><rights>COPYRIGHT 2020 AVES</rights><rights>Copyright 2020 by Turkish Society of Gastroenterology 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c524t-90f1f340f1d01027b6ff7edac2a0551e93a384dc3cabff5d284e9a6909e0ddfe3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7075684/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7075684/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32009613$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Guo-Xiang</creatorcontrib><creatorcontrib>Yu, Guang</creatorcontrib><creatorcontrib>Xiang, Yan-Li</creatorcontrib><creatorcontrib>Miu, Yang-De</creatorcontrib><creatorcontrib>Wang, Hong-Gang</creatorcontrib><creatorcontrib>Xu, Mei-Dong</creatorcontrib><creatorcontrib>Endoscopy Center, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China</creatorcontrib><creatorcontrib>Department of Gastroenterology, Taizhou Municipal Hospital, Taizhou, Zhejiang, China</creatorcontrib><title>Submucosal tunneling endoscopic resection for large symptomatic submucosal tumors of the esophagus: A clinical analysis of 24 cases</title><title>The Turkish journal of gastroenterology</title><addtitle>Turk J Gastroenterol</addtitle><description>Studies evaluating submucosal tunneling endoscopic resection (STER) for the treatment of upper gastrointestinal submucosal tumors (SMTs) have recently increased. However, the efficacy and safety of STER for the treatment of large symptomatic SMTs in the esophagus have not been well investigated. The aim of the present study was to evaluate the efficacy and safety of STER for the treatment of large symptomatic SMTs in the esophagus.
A total of 24 patients with large symptomatic SMTs in the esophagus who underwent STER in our hospitals between January 2015 and May 2018 were included in the study. The tumors were confirmed to be of muscularis propria layer origin. Treatment outcomes, complications, and follow-up results were retrospectively analyzed.
All 24 lesions were resected en bloc with STER. The mean maximum transverse diameter of the lesions was 4.7 (3.5-6.5) cm. The mean maximum longitudinal diameter of the lesions was 2.1 (1.5-3.0) cm. The mean duration from mucosal incision to complete mucosal closure was 65 (50-115) min. Postoperative pathological diagnosis confirmed 18 cases with leiomyomas, 4 cases with stromal tumors, and 2 cases with schwannomas. There were no major complications. There were no residual lesions or disease recurrence during follow-up.
STER is safe and effective for the treatment of large symptomatic SMTs of muscularis propria layer origin in the esophagus.</description><subject>Care and treatment</subject><subject>Diseases</subject><subject>Endoscopy</subject><subject>Esophageal cancer</subject><subject>Hospitals</subject><subject>Original</subject><subject>Photographic industry</subject><subject>Recurrence (Disease)</subject><subject>Relapse</subject><subject>Surgery</subject><subject>Tumors</subject><issn>1300-4948</issn><issn>2148-5607</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNqdks2LFDEQxYMo7rh69SgBL156rCTdSbcHYVj8ggUP6jlk0pWeLN1Jm3QLc_YfN7O7rit4koIUpH7vUQmPkOcMtg1r-Ovlathy4LBlHUj-gGw4q9uqkaAekg0TAFXd1e0ZeZLzFYBomeSPyZngAJ1kYkN-fln302pjNiNd1hBw9GGgGPqYbZy9pQkz2sXHQF1MdDRpQJqP07zEySxlnu_rp5gyjY4uB6SY43www5rf0B21xdbbwphgxmP21xSvqTUZ81PyyJkx47Pbfk6-vX_39eJjdfn5w6eL3WVlG14vVQeOOVGXswcGXO2lcwp7Y7mBpmHYCSPaurfCmr1zTc_bGjsjO-gQ-t6hOCdvb3znsjP2FsOSzKjn5CeTjjoar_-eBH_QQ_yhFahGtnUxeHVrkOL3FfOiJ58tjqMJGNesuWhANIIpVtCXN-hgRtQ-uFgc7QnXO8kLojouC7X9B1Wqx8nbGND5cv8_Ag6yU0r9EdgUc07o7p7LQJ8SpEuC9ClB-jpBRfDi_ifd4b8jI34B0u_EWA</recordid><startdate>20200101</startdate><enddate>20200101</enddate><creator>Wang, Guo-Xiang</creator><creator>Yu, Guang</creator><creator>Xiang, Yan-Li</creator><creator>Miu, Yang-De</creator><creator>Wang, Hong-Gang</creator><creator>Xu, Mei-Dong</creator><general>AVES</general><general>Turkish Society of Gastroenterology</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IAO</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20200101</creationdate><title>Submucosal tunneling endoscopic resection for large symptomatic submucosal tumors of the esophagus: A clinical analysis of 24 cases</title><author>Wang, Guo-Xiang ; Yu, Guang ; Xiang, Yan-Li ; Miu, Yang-De ; Wang, Hong-Gang ; Xu, Mei-Dong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c524t-90f1f340f1d01027b6ff7edac2a0551e93a384dc3cabff5d284e9a6909e0ddfe3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Care and treatment</topic><topic>Diseases</topic><topic>Endoscopy</topic><topic>Esophageal cancer</topic><topic>Hospitals</topic><topic>Original</topic><topic>Photographic industry</topic><topic>Recurrence (Disease)</topic><topic>Relapse</topic><topic>Surgery</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Guo-Xiang</creatorcontrib><creatorcontrib>Yu, Guang</creatorcontrib><creatorcontrib>Xiang, Yan-Li</creatorcontrib><creatorcontrib>Miu, Yang-De</creatorcontrib><creatorcontrib>Wang, Hong-Gang</creatorcontrib><creatorcontrib>Xu, Mei-Dong</creatorcontrib><creatorcontrib>Endoscopy Center, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China</creatorcontrib><creatorcontrib>Department of Gastroenterology, Taizhou Municipal Hospital, Taizhou, Zhejiang, China</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale Academic OneFile</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Turkish journal of gastroenterology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Guo-Xiang</au><au>Yu, Guang</au><au>Xiang, Yan-Li</au><au>Miu, Yang-De</au><au>Wang, Hong-Gang</au><au>Xu, Mei-Dong</au><aucorp>Endoscopy Center, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China</aucorp><aucorp>Department of Gastroenterology, Taizhou Municipal Hospital, Taizhou, Zhejiang, China</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Submucosal tunneling endoscopic resection for large symptomatic submucosal tumors of the esophagus: A clinical analysis of 24 cases</atitle><jtitle>The Turkish journal of gastroenterology</jtitle><addtitle>Turk J Gastroenterol</addtitle><date>2020-01-01</date><risdate>2020</risdate><volume>31</volume><issue>1</issue><spage>42</spage><epage>48</epage><pages>42-48</pages><issn>1300-4948</issn><eissn>2148-5607</eissn><abstract>Studies evaluating submucosal tunneling endoscopic resection (STER) for the treatment of upper gastrointestinal submucosal tumors (SMTs) have recently increased. However, the efficacy and safety of STER for the treatment of large symptomatic SMTs in the esophagus have not been well investigated. The aim of the present study was to evaluate the efficacy and safety of STER for the treatment of large symptomatic SMTs in the esophagus.
A total of 24 patients with large symptomatic SMTs in the esophagus who underwent STER in our hospitals between January 2015 and May 2018 were included in the study. The tumors were confirmed to be of muscularis propria layer origin. Treatment outcomes, complications, and follow-up results were retrospectively analyzed.
All 24 lesions were resected en bloc with STER. The mean maximum transverse diameter of the lesions was 4.7 (3.5-6.5) cm. The mean maximum longitudinal diameter of the lesions was 2.1 (1.5-3.0) cm. The mean duration from mucosal incision to complete mucosal closure was 65 (50-115) min. Postoperative pathological diagnosis confirmed 18 cases with leiomyomas, 4 cases with stromal tumors, and 2 cases with schwannomas. There were no major complications. There were no residual lesions or disease recurrence during follow-up.
STER is safe and effective for the treatment of large symptomatic SMTs of muscularis propria layer origin in the esophagus.</abstract><cop>Turkey</cop><pub>AVES</pub><pmid>32009613</pmid><doi>10.5152/tjg.2020.19062</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1300-4948 |
| ispartof | The Turkish journal of gastroenterology, 2020-01, Vol.31 (1), p.42-48 |
| issn | 1300-4948 2148-5607 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7075684 |
| source | EZB-FREE-00999 freely available EZB journals; PubMed Central |
| subjects | Care and treatment Diseases Endoscopy Esophageal cancer Hospitals Original Photographic industry Recurrence (Disease) Relapse Surgery Tumors |
| title | Submucosal tunneling endoscopic resection for large symptomatic submucosal tumors of the esophagus: A clinical analysis of 24 cases |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T13%3A01%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Submucosal%20tunneling%20endoscopic%20resection%20for%20large%20symptomatic%20submucosal%20tumors%20of%20the%20esophagus:%20A%20clinical%20analysis%20of%2024%20cases&rft.jtitle=The%20Turkish%20journal%20of%20gastroenterology&rft.au=Wang,%20Guo-Xiang&rft.aucorp=Endoscopy%20Center,%20Shanghai%20East%20Hospital,%20Tongji%20University%20School%20of%20Medicine,%20Shanghai,%20China&rft.date=2020-01-01&rft.volume=31&rft.issue=1&rft.spage=42&rft.epage=48&rft.pages=42-48&rft.issn=1300-4948&rft.eissn=2148-5607&rft_id=info:doi/10.5152/tjg.2020.19062&rft_dat=%3Cgale_pubme%3EA623177926%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2350353171&rft_id=info:pmid/32009613&rft_galeid=A623177926&rfr_iscdi=true |